Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572981
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving Hot Flashes in Menopausal WomenUniversity Hospital, ToulouseNot Yet RecruitingNot Applicable
NCT07572981Not Yet Recruiting
Not Applicable
Study of the Effectiveness of Clinical Hypnosis and Self-hypnosis in Relieving H...University Hospital, Toul...
NCT07574268
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled TrialMenoufia UniversityCompletedPhase 4
NCT07574268Completed
Phase 4
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men Wi...Menoufia University
NCT07573189
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Movement, and Joint Ange of Motion in Collegiate Athletes.University of RedlandsActive Not RecruitingNot Applicable
NCT07573189Active Not Recruiting
Not Applicable
The Effects of Recovery Compression Boots on Blood Lactate Levels, Functional Mo...University of Redlands
NCT07573683
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive IndividualsFoundation University IslamabadRecruitingNot Applicable
NCT07573683Recruiting
Not Applicable
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary...Foundation University Isl...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07572318
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometry on a VERITON™ CZT CameraCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07572318Not Yet Recruiting
Not Applicable
Pilot Study on the Feasibility of High-energy Collimation With Optimized Geometr...Central Hospital, Nancy,...
NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou General HospitalCompletedNot Applicable
NCT07574372Completed
Not Applicable
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical MastectomyProf. R. D. Kandou Genera...
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07572110
Project Independence: Randomized Controlled TrialUniversity of MiamiNot Yet RecruitingNot Applicable
NCT07572110Not Yet Recruiting
Not Applicable
Project Independence: Randomized Controlled TrialUniversity of Miami
NCT07573579
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest Hospital NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07573579Not Yet Recruiting
Not Applicable
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest...
NCT07573020
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone LossMansoura UniversityCompletedNot Applicable
NCT07573020Completed
Not Applicable
Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and M...Mansoura University
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572253
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial FibrillationCentral China Fuwai Hospital of Zhengzhou UniversityNot Yet RecruitingNot Applicable
NCT07572253Not Yet Recruiting
Not Applicable
A Study of Using CARTO SOUND™ FAM to Guide Pulsed Field Ablation for Atrial Fibr...Central China Fuwai Hospi...
NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back PainIstinye UniversityCompletedNot Applicable
NCT07573254Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07573566
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardiac ArrestKlinikum Klagenfurt am WörtherseeNot Yet RecruitingNot Applicable
NCT07573566Not Yet Recruiting
Not Applicable
Abdominal Aortic Tourniquet Application for Non-Traumatic Out-of-Hospital Cardia...Klinikum Klagenfurt am Wö...
Result Breakdown
Not yet recruiting11 (55%)
Completed5 (25%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
not_applicable15 (75%)
Not Specified2 (10%)
Phase 41 (5%)
Phase 11 (5%)
Phase 21 (5%)